Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

277 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P. Hanauer SB, et al. Among authors: fedorak rn. Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030. Gastroenterology. 2006. PMID: 16472588 Clinical Trial.
FK506 increases permeability in rat intestine by inhibiting mitochondrial function.
Madsen KL, Yanchar NL, Sigalet DL, Reigel T, Fedorak RN. Madsen KL, et al. Among authors: fedorak rn. Gastroenterology. 1995 Jul;109(1):107-14. doi: 10.1016/0016-5085(95)90274-0. Gastroenterology. 1995. PMID: 7540994
Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group.
Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW. Irvine EJ, et al. Among authors: fedorak rn. Gastroenterology. 1994 Feb;106(2):287-96. doi: 10.1016/0016-5085(94)90585-1. Gastroenterology. 1994. PMID: 8299896 Clinical Trial.
Interleukin 10 modulates ion transport in rat small intestine.
Madsen KL, Tavernini MM, Mosmann TR, Fedorak RN. Madsen KL, et al. Among authors: fedorak rn. Gastroenterology. 1996 Oct;111(4):936-44. doi: 10.1016/s0016-5085(96)70061-6. Gastroenterology. 1996. PMID: 8831588
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, Dallaire C, Rossman R, Saibil F, Lariviere L. Sutherland LR, et al. Among authors: fedorak rn. Gastroenterology. 1997 Apr;112(4):1069-77. doi: 10.1016/s0016-5085(97)70117-3. Gastroenterology. 1997. PMID: 9097988 Clinical Trial.
Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion.
Madsen KL, Lewis SA, Tavernini MM, Hibbard J, Fedorak RN. Madsen KL, et al. Among authors: fedorak rn. Gastroenterology. 1997 Jul;113(1):151-9. doi: 10.1016/s0016-5085(97)70090-8. Gastroenterology. 1997. PMID: 9207273
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.
van Deventer SJ, Elson CO, Fedorak RN. van Deventer SJ, et al. Among authors: fedorak rn. Gastroenterology. 1997 Aug;113(2):383-9. doi: 10.1053/gast.1997.v113.pm9247454. Gastroenterology. 1997. PMID: 9247454 Clinical Trial.
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.
Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Madsen KL, et al. Among authors: fedorak rn. Gastroenterology. 1999 May;116(5):1107-14. doi: 10.1016/s0016-5085(99)70013-2. Gastroenterology. 1999. PMID: 10220502
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH Jr. Sandborn WJ, et al. Among authors: fedorak rn. Gastroenterology. 1999 Sep;117(3):527-35. doi: 10.1016/s0016-5085(99)70445-2. Gastroenterology. 1999. PMID: 10464128 Clinical Trial.
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.
Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN. Madsen KL, et al. Among authors: fedorak rn. Gastroenterology. 2000 Jun;118(6):1094-105. doi: 10.1016/s0016-5085(00)70362-3. Gastroenterology. 2000. PMID: 10833484
277 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback